NeuroTweeter's profile picture. Professor of Neurology. Head of Neuromuscular Unit Hadassah University Hospital, Jerusalem, Israel. ALS researcher.

Marc Gotkine

@NeuroTweeter

Professor of Neurology. Head of Neuromuscular Unit Hadassah University Hospital, Jerusalem, Israel. ALS researcher.

Some reputable high impact journal publishers seem to be totally bypassing human involvement in their review invitations.

NeuroTweeter's tweet image. Some reputable  high impact journal publishers seem to be totally bypassing human involvement  in their review invitations.

Military Service Roles and ALS Among Veterans: A Matched Case–Control Study - Honig - Annals of Clinical and Translational Neurology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/ac…


Akt Activation With IPL344 Treatment for Amyotrophic Lateral Sclerosis: First in Human, Open‐Label Study - Gotkine - Muscle & Nerve - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/mu…


Marc Gotkine reposted

This is absolutely terrifying. News of a plane landing in Russia from Israel sparked a Jew hating mob. This is exactly what Hamas and the Islamic regime in Iran wanted to happen all over the world as a result of October 7th. This cannot be happening in 2023 - yet it is.


Marc Gotkine reposted

Serious question: Does anyone doubt that Israel is capable of murdering everyone in Gaza indiscriminately in about a day?* So, if we're 19 days into this, sending Gazans from the north to the south, and risking our soldier's lives with a ground invasion, what does that tell you?


Marc Gotkine reposted

Why complement is activated and damages the peripheral nervous system in Guillain Barre Syndrome? The Nodes of Ranvier lack CD59 and are hence not protected from complement terminal attack. The myelin unit in human PNS is protected by CD59 and CD55, but not by CD46 or CD35.…


Marc Gotkine reposted

Imagine if within days of the Al-Qaeda attack on 9/11 which killed nearly 3,000 American citizens or the ISIS mass terror attack in Paris in 2015, that murdered 130 innocent people, a group of students on American campuses were holding rallies in support of that terror attack,…


Marc Gotkine reposted

What side are you on ? Peace and prosperity or radicalism and destruction ??


Marc Gotkine reposted

Watch this, share it and then join us. We need every voice we can get in this fight. ♥️ A huge thank you to @CBSSunday and @LeeCowanCBS for amplifying our voices. It matters. cbsnews.com/video/race-to-…


Thread by @trvrb: With #COVID19 vaccine efficacy of ~95%, I'm looking forward to vaccine distribution in 2021 bringing the pandemic under control. However, I'm concerned that we'll see antigenic drift of SARS-CoV-2 ...… threadreaderapp.com/thread/1340409…


Having same issue. Spotify crashing

This post is unavailable.

Important new information

Important: New paper shows that COVID-19 may remain infectious on surfaces up to a few days (like SARS) "Aerosol and fomite transmission of HCoV-19 are plausible, as the virus can remain viable in aerosols for multiple hours and on surfaces up to days" medrxiv.org/content/10.110…

segal_eran's tweet image. Important: New paper shows that COVID-19 may remain infectious on surfaces up to a few days (like SARS)

"Aerosol and fomite transmission
of HCoV-19 are plausible, as the virus can remain viable in aerosols for multiple hours and on surfaces up to days"

medrxiv.org/content/10.110…


Marc Gotkine reposted

expert reaction to study on ALS and the gut microbiome sciencemediacentre.org/expert-reactio…


Marc Gotkine reposted

Gut Microbiome May Alter ALS Progression in Mice: In 1993 amyotrophic lateral sclerosis ALS was linked to a genetic mutation in the SOD1 gene. It was a landmark discovery as were others like it at the time linking devastating neurological diseases to… bioportfol.io/R8swtz


Marc Gotkine reposted

This study in @nature reports of a functional link between the #microbiome and the #neurodegenerative disease, Amyotrophic Lateral Sclerosis (#ALS). @EranElinav @segal_eran @NeuroTweeter @WeizmannScience nature.com/articles/s4158…


Loading...

Something went wrong.


Something went wrong.